share_log

Keybanc Maintains Overweight on Progyny, Lowers Price Target to $43

Benzinga ·  Feb 28 18:09

Keybanc maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $45 to $43.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment